Meishia specializes in healthcare billing, auditing, and insurance claims resolution, ensuring that patients can
She became involved in juvenile myositis research because her daughter Keyani was diagnosed with juvenile myositis in 2017.
Research and progress is deeply important to Meishia because she knows that children like hers need access to better treatments, with fewer side effects, so they can enjoy a better quality of life. She also feels strongly that removing some of the “trial and error” from the current treatment plans will improve quality of life for children.